Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Aspen Insurance (AHL) Upgraded By UBS, Intrexon (XON) Surged On Q3 Results

|Includes:Aspen Insurance Holdings Limited (AHL), XON

https://staticseekingalpha.a.ssl.fastly.net/uploads/2013/11/10/saupload_ahl.jpg Aspen Insurance Holdings Ltd. (NYSE:AHL)

AHL stock surged $0.64 (or +1.65%) to $39.51 and 1,486,480 shares exchanged hands on Friday's market activity.

AHL was upgraded from Neutral to Buy with price target of $46 by brokerage firm UBS.

AHL recently reported net income after tax of $107.4 million, or $1.43 diluted net income per share, for the third quarter of 2013.

https://staticseekingalpha.a.ssl.fastly.net/uploads/2013/11/10/saupload_ahl_chart.png

AHL provides reinsurance and insurance coverage to clients in various domestic and global markets through wholly-owned subsidiaries and offices in Bermuda, France, Germany, Ireland, Singapore, Switzerland, the United Kingdom and the United States.

More about Aspen Insurance Holdings Ltd. (NYSE:AHL) at www.aspen.co.

**

**

https://staticseekingalpha.a.ssl.fastly.net/uploads/2013/11/10/saupload_xon.jpg Intrexon Corporation (NYSE:XON)

Shares of XON jumped $1.68 (or +9.52%) to $19.33, after the company reported strong performance in its financial results compared with last year.

For the third quarter 2013, XON posted total revenues of $6.1 million, an increase of 109.7% compared to $2.9 million in the same period the prior year, and net income attributable to XON of $15.4 million, or $0.15 cents per common share, compared to a net loss of $20.5 million for the third quarter 2012.

https://staticseekingalpha.a.ssl.fastly.net/uploads/2013/11/10/saupload_xon_chart.png

XON is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy and the Environment to create biologically-based products that improve the quality of life and the health of the planet. Through the company's proprietary UltraVector(NYSE:R) platform, which delivers unprecedented control over the quality, function, and performance of living cells, XON provides its partners with industrial-scale design and development of complex biological systems. XON calls its synthetic biology approach and integrated technologies Better DNA(R).

More about Intrexon Corporation (NYSE:XON) at www.dna.com.

**

Read Full Disclaimer at www.drstockpick.com/disclaimer

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Stocks: AHL, XON